Results 231 to 240 of about 152,699 (284)

Toxicities of the platinum antineoplastic agents

Expert Opinion on Drug Safety, 2003
The platinum agents (cisplatin, carboplatin and oxaliplatin) are among the most useful anticancer agents available to oncologists. The drugs have the potential to produce both mild and more serious side effects. However, in general, the platinum agents can be delivered with acceptable toxicity, even when used in combination chemotherapy regimens ...
Maurie Markman
exaly   +3 more sources

Ocular Toxicity of Antineoplastic Agents

Ophthalmology, 1983
The increased use of chemotherapeutic agents has resulted in longer patient survival; consequently, the ophthalmologist is seeing more patients with adverse ocular side effects secondary to these antineoplastic agents. Many of these drugs cause aggravating ocular irritation (fluorouracil, methotrexate), canalicular fibrosis with epiphora (fluorouracil),
F T Fraunfelder, S Martha Meyer
exaly   +3 more sources

The Challenges of Oral Agents as Antineoplastic Treatments

Seminars in Oncology Nursing, 2011
OBJECTIVE: Given the increasing use of oral antineoplastic agents in cancer management, patient adherence is critical to successful treatment outcomes.
Barbara Given, Sandra L Spoelstra, Marcia Grant   +2 more
exaly   +3 more sources

Neurotoxicity of antineoplastic agents

Critical Reviews in Oncology/Hematology, 1993
to review the neurotoxicity associated with antineoplastic agents.four hundred articles, abstracts and book chapters were selected for review. One hundred and ninety (articles, book chapters and abstracts) were identified as representative of the important aspects of neurotoxicity to be presented in this review.in general the dose, schedule and route ...
M, Hussain, A J, Wozniak, M B, Edelstein
openaire   +2 more sources

Possible Antineoplastic Agents II

Journal of Pharmaceutical Sciences, 1975
A few thalidomide and glutarimide derivatives were synthesized. Several compounds possessed significant antineoplastic activity against Ehrlich ascites carcinoma in Swiss albino mice.
A U, De, D, Pal
openaire   +3 more sources

Antineoplastic agents

Critical Care Nursing Quarterly, 1996
Advances in the field of oncology have led to the development of many antineoplastic agents for the treatment of cancer. Combination with other agents and modalities, along with dose intensification, has resulted in more toxicities, often requiring careful management and monitoring in the critical care setting.
openaire   +2 more sources

Hypersensitivity to Antineoplastic Agents

Current Pharmaceutical Design, 2008
The need to offer first line therapy for primary and recurrent cancers has spurred the clinical development of rapid desensitizations for chemotherapy and monoclonal antibodies. Rapid desensitizations allow patients to be treated with medications to which they have presented with hypersensitivity reactions (HSRs), including anaphylaxis.
openaire   +2 more sources

Thalidomide: An antineoplastic agent

Current Oncology Reports, 2002
It has been more than three decades since the withdrawal of thalidomide from the marketplace. Thalidomide is attracting growing interest because of its reported immunomodulatory and anti-inflammatory properties. Current evidence indicates that thalidomide reduces the activity of the inflammatory cytokine tumor necrosis factor-alpha by accelerating the ...
openaire   +2 more sources

Estimating National-Level Exposure to Antineoplastic Agents in the Workplace: CAREX Canada Findings and Future Research Needs

Annals of Work Exposures and Health, 2017
Objectives:Occupational exposure to antineoplastic agents occurs in various environments and is associated with increased cancer risk and adverse reproductive outcomes.
Amy L Hall, Paul A Demers, George Astrakianakis   +2 more
exaly   +2 more sources

Interactions of antimicrobial agents and antineoplastic agents

Journal of Antimicrobial Chemotherapy, 1986
The in-vitro interactions of four antimicrobial agents (piperacillin, dibekacin, minocycline, norfloxacin) and four antineoplastic agents (mitomycin C, bleomycin, doxorubicin, 5-fluorouracil) were examined by the chequerboard dilution method using 108 clinical isolates of four species of Gram-negative bacilli.
Y, Yamashiro, Y, Fukuoka, A, Yotsuji, T, Yasuda, I, Saikawa, Y, Ueda   +5 more
openaire   +2 more sources